Company Directory - Publicis Health Media
Company Details - Publicis Health Media
Publicis Health Media
WebsitePublicis Health Media is a healthcare marketing agency specializing in media strategy and implementation. The agency focuses on patient engagement and health brand promotion through tailored communication solutions in the healthcare industry.
CCI Score
CCI Score: Publicis Health Media
-66.18
0.06%
Latest Event
Publicis Health Media's $350 Million Opioid Settlement
Publicis Health Media, a division of Publicis Health, reached a $350 million settlement over allegations that it promoted opioid products for Purdue Pharma from 2010 to 2019, contributing to the US opioid crisis.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
ARCHITECT
Publicis Health Media is currently rated as an Architect.
Latest Events
- FEB022024
Publicis Health Media, a division of Publicis Health, reached a $350 million settlement over allegations that it promoted opioid products for Purdue Pharma from 2010 to 2019, contributing to the US opioid crisis.
-70
Business Practices and Ethical Responsibility
March 28
The settlement highlights deep ethical lapses in business practices. Publicis Health Media's role in designing marketing strategies for opioid manufacturer Purdue Pharma, which contributed to the opioid crisis, reflects irresponsible corporate behavior that harmed public health and marginalized communities. Such a case falls squarely under unethical business practices, warranting a strongly negative score.
- FEB012024
Publicis Health Media, part of the Publicis Groupe, agreed to pay $350 million to settle lawsuits alleging its predatory and deceptive marketing practices for OxyContin and other opioids. The settlement followed revelations that the agency provided physicians with digital recorders to analyze patient-prescriber conversations, raising significant concerns over privacy and ethical conduct amid the opioid crisis.
-70
Business Practices and Ethical Responsibility
March 28
Publicis Health Media engaged in predatory and deceptive marketing practices that contributed to the opioid crisis by aggressively promoting Purdue Pharma’s products. Such unethical business practices undermine public health and exploit vulnerable communities.
Advertising agency for OxyContin agrees to pay $350 million rather than face lawsuits
-60
Provision of Repressive Technologies
March 28
The agency provided physicians with digital recorders to analyze conversations between prescribers and patients. This practice raises serious privacy concerns and signals a misuse of technology for monitoring purposes, reflecting a troubling use of data collection methods that could be exploited in authoritarian contexts.
Advertising agency for OxyContin agrees to pay $350 million rather than face lawsuits
- FEB012024Opioid Marketing Settlement
-61.76
Publicis Health Media agreed to pay $350 million to settle allegations of developing predatory and deceptive opioid marketing strategies for Purdue Pharma, as announced by New York Attorney General Letitia James on February 1, 2024. The settlement was a result of a coalition effort by state attorneys general to address harmful marketing practices contributing to the opioid crisis.
-70
Business Practices and Ethical Responsibility
March 28
The settlement reveals unethical business practices by Publicis Health Media, where deceptive and predatory opioid marketing strategies were employed, adversely affecting vulnerable populations and contributing to the opioid crisis. This problematic approach to marketing undermines corporate ethical responsibility.
Publicis Health to pay $350 million to settle US opioid marketing lawsuit; landmark settlement
- FEB012024
Publicis Health Media agreed to pay $350 million to settle claims that its deceptive and predatory marketing practices for Purdue Pharma significantly contributed to the opioid crisis, leading to widespread abuse, overdose deaths, and public health devastation.
-80
Business Practices and Ethical Responsibility
March 28
The company's role in developing and executing deceptive advertising campaigns for opioid manufacturers, particularly Purdue Pharma, directly facilitated overprescribing and abuse of opioids. This unethical business practice contributed to the opioid epidemic and represents a severe breach of ethical responsibility.
Publicis To Pay $350 Million For Its Role In The Opioid Crisis
- FEB012024
Publicis Health Media agreed to a $350 million settlement with New York Attorney General Letitia James over its deceptive marketing practices for opioids. The settlement, which prohibits the company from future opioid-related contracts and mandates the public disclosure of internal documents, underscores the agency's role in exacerbating the opioid crisis.
-85
Business Practices and Ethical Responsibility
March 28
Publicis Health Media engaged in predatory and deceptive marketing practices by promoting opioids under false safety claims, contributing significantly to the opioid crisis. The resulting legal settlement reflects a serious breach of ethical responsibility in business practices, harming vulnerable communities.
Attorney General James Secures $350 Million from Publicis for its Role in the Opioid Crisis
- FEB012024
Publicis Health Media reached a $350 million settlement over lawsuits alleging deceptive opioid marketing practices that contributed to the opioid crisis, involving its work with agencies like Rosetta and partnerships with Purdue Pharma and other pharmaceutical companies. This legal resolution underscores significant ethical failures in their marketing strategy.
-80
Business Practices and Ethical Responsibility
April 1
The company’s deceptive marketing practices for opioids have been linked to exacerbating the opioid crisis, adversely impacting vulnerable communities. The large settlement highlights an instance of unethical business conduct and lack of accountability, which is severely at odds with ethical, community-focused practices.
Alternatives
Corporation
0.00
Corporation
0.00
Toronto, Canada
-0.06
London, United Kingdom
18.57
London, United Kingdom
0.00
Tokyo, Japan
-41.93
Paris, France
-45.01
Corporation
30.58
Corporation
29.49
Corporation
21.87
Industries
- 541511
- Custom Computer Programming Services
- 541613
- Marketing Consulting Services
- 541810
- Advertising Agencies